References
1. Weller J, Budson A. Current understanding of Alzheimer’s disease
diagnosis and treatment. Vol. 7, F1000Research. 2018.
2. Quitterer U, AbdAlla S. Improvements of symptoms of Alzheimer‘s
disease by inhibition of the angiotensin system. Vol. 154,
Pharmacological Research. 2020.
3. Wyss JM, Kadish I, Van Groen T. Age-related decline in spatial
learning and memory: Attenuation by captopril. Clin Exp Hypertens.
2003;25(7).
4. Liu S, Ando F, Fujita Y, Liu J, Maeda T, Shen X, et al. A clinical
dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous
ACE deletion exacerbate Alzheimer’s disease pathology in mice. J Biol
Chem. 2019;294(25).
5. Hemming ML, Selkoe DJ. Amyloid β-protein is degraded by cellular
angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. J
Biol Chem. 2005;280(45).
6. Schwartzentruber J, Cooper S, Liu JZ, Barrio-Hernandez I, Bello E,
Kumasaka N, et al. Genome-wide meta-analysis, fine-mapping and
integrative prioritization implicate new Alzheimer’s disease risk genes.
Nat Genet. 2021;53(3).
7. Bone WP, Siewert KM, Jha A, Klarin D, Damrauer SM, Chang KM, et al.
Multi-trait association studies discover pleiotropic loci between
Alzheimer’s disease and cardiometabolic traits. Alzheimers Res Ther.
2021;13(1).
8. Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD,
Wallace C, et al. Bayesian Test for Colocalisation between Pairs of
Genetic Association Studies Using Summary Statistics. PLoS Genet.
2014;10(5).
9. Foley CN, Staley JR, Breen PG, Sun BB, Kirk PDW, Burgess S, et al. A
fast and efficient colocalization algorithm for identifying shared
genetic risk factors across multiple traits. Nat Commun. 2021;12(1).
10. de Klein N, Tsai EA, Vochteloo M, Baird D, Huang Y, Chen C-Y, et al.
Brain expression quantitative trait locus and network analysis reveals
downstream effects and putative drivers for brain-related diseases.
bioRxiv. 2021;
11. Evangelou E, Warren HR, Mosen-Ansorena D, Mifsud B, Pazoki R, Gao H,
et al. Genetic analysis of over 1 million people identifies 535 new loci
associated with blood pressure traits. Nat Genet. 2018;50(10).
12. de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V,
Jansen I, et al. Common variants in Alzheimer’s disease: Novel
association of six genetic variants with AD and risk stratification by
polygenic risk scores. medRxiv. 2020;
13. de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V,
Jansen IE, et al. Common variants in Alzheimer’s disease and risk
stratification by polygenic risk scores. Nat Commun 2021 121. 2021 Jun
7;12(1):1–16.
14. Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S,
Chang D, et al. Identification of novel risk loci, causal insights, and
heritable risk for Parkinson’s disease: a meta-analysis of genome-wide
association studies. Lancet Neurol. 2019;18(12).
15. Traylor M, Persyn E, Tomppo L, Klasson S, Abedi V, Bakker MK, et al.
Genetic basis of lacunar stroke: a pooled analysis of individual patient
data and genome-wide association studies. Lancet Neurol. 2021;20(5).
16. Persyn E, Hanscombe KB, Howson JMM, Lewis CM, Traylor M, Markus HS.
Genome-wide association study of MRI markers of cerebral small vessel
disease in 42,310 participants. Nat Commun. 2020;11(1).
17. Lee JJ, Wedow R, Okbay A, Kong E, Maghzian O, Zacher M, et al. Gene
discovery and polygenic prediction from a genome-wide association study
of educational attainment in 1.1 million individuals. Nat Genet.
2018;50(8).
18. O’Caoimh R, Healy L, Gao Y, Svendrovski A, Kerins DM, Eustace J, et
al. Effects of centrally acting angiotensin converting enzyme inhibitors
on functional decline in patients with alzheimer’s disease. J
Alzheimer’s Dis. 2014;40(3).
19. Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, et
al. Angiotensin-converting enzyme inhibitors and cognitive decline in
older adults with hypertension: Results from the cardiovascular health
study. Arch Intern Med. 2009;169(13).
20. Burgess S, Butterworth A, Malarstig A, Thompson SG. Use of Mendelian
randomisation to assess potential benefit of clinical intervention. BMJ.
2012 Nov 6;345:e7325.
Table 1: Sources for genetic data